Congress Materials

Medical Information
Gulf Countries
 

This medical information website is intended only for healthcare professionals in the following Gulf Countries (UAE, Oman, Bahrain, Qatar and Kuwait). This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient.

Please choose the category that best describes you.

I am a Healthcare Professional registered to practice in UAE or Oman or Bahrain or Qatar or KuwaitYes, I am a Healthcare Professional registered to practice in UAE or Oman or Bahrain or Qatar or Kuwait
SelectI am a Healthcare Professional registered to practice in UAE or Oman or Bahrain or Qatar or KuwaitYes, I am a Healthcare Professional registered to practice in UAE or Oman or Bahrain or Qatar or Kuwait
I am a patient / caregiverNo, go back to the patient portal
SelectI am a patient / caregiverNo, go back to the patient portal
I am a Healthcare Professional in another country.

Congress Materials

The information on this page pertains to select congresses, congress materials, therapeutic and disease areas. It is not intended to serve as a comprehensive overview of all congresses, congress materials, therapeutic and disease areas.
Oral Presentation
Zhao Y, Laird AD, Roberts K, Yafawi R, Kantarjian H, DeAngelo DJ, Stelljes M, Liedtke M, Stock W, Gökbuget N, O’Brien S, Jabbour E, Cassaday RD, Loyd MR, Olsen S, Neale G, Liu X, Vandendries E, Mullighan CG, Advani A April 10, 2022 AACR 2022 Hematology

Exploration of Association of Leukemic Molecular Profile with Efficacy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia Treated with Inotuzumab Ozogamicin in the Phase 3 INO-VATE Trial

View Presentation View Abstract Plain Language Summary
Oral Presentation
de Bono JS, Mehra N, Laird AD, Castro E, Barthelemy P, Delva R, Scagliotti GV, Maruzzo M, Stirling A, Machiels J-P,  Dumez H, Renard V, Hopkins JF, Albacker LA, Chen H-C, Healy CG,  Chelliserry J, Dorff T, Fizazi K April 11, 2022 AACR 2022 Prostate Cancer

TALAPRO-1: Talazoparib Monotherapy in Metastatic Castration-Resistant Prostate Cancer (mCRPC) With Tumor DNA Damage Response Alterations(DDRm) — Exploration of Genomic Loss of Heterozygosity (gLOH) and Potential Associations With Antitumor Activity

View Presentation View Video View Abstract Plain Language Summary
Poster
Dummer R, Pathan N, Zhu Z, Robert C, Arance A, de Groot JWB, Garbe C, Gogas HJ, Gutzmer R, Krajsova I, Liszkay G, Loquai C, Mandala M, Schadendorf D, Yamazaki N, Edwards M, Cantey-Kiser J, di Pietro A, Deng S, Ascierto PA, Flaherty K April 12, 2022 AACR 2022 Skin Cancer

Molecular Correlates of Clinical Benefit From Circulating Tumor DNA (ctDNA): Analysis of the COLUMBUS Study

View Presentation
Poster
Solomon BJ, Bauer T, Mok T, Liu G, Mazieres J, de Marinis F, Goto Y, Kim D-W, Wu Y-L, Dvorkin M, Jassem J, López-López F, Soo R, Polli A, Dall'O' E, Iadeluca L, Toffalorio F, Felip E  April 12, 2022 AACR 2022 Lung Cancer

Updated Efficacy and Safety From the Phase 3 CROWN Study of First-Line Lorlatinib vs Crizotinib in Advanced Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small Cell Lung Cancer (NSCLC)

View Presentation View Video View Abstract Plain Language Summary